The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

What's New at The Body

HIV/AIDS News You Can Use

April 9, 2001

New AIDS Treatment Expert at The Body

The Body is pleased to announce the addition of a new expert in our popular General Treatment Strategies Forum. Dr. Judith Aberg is director of HIV Services at Washington University in St. Louis, Missouri. Click here to ask her your questions.

The April Visual AIDS Web Gallery

The April Visual AIDS Web Gallery, featuring artwork by HIV positive artists is now live! Click here to see art chosen by Sina Najafi and Gregory Williams.

Clinical Trial Design

Clinical trial design is one of the more important elements in getting new medications to fight HIV approved. Take a look at Treatment Action Group's reporting of a recent meeting regarding clinical trial design for HIV-infected people with limited antiretroviral therapeutic options.

Clinical Trials Now Enrolling

Interested in joining a clinical trial? Click here to see what major clinical trials are going on right now throughout the U.S.

When Is the Best Time to Start Treatment?

If there is any clear message from the last fifteen years of research, it is that there is no single treatment strategy that is "best" for everyone. Project Inform takes an in depth look at when is the best time to start treatment.

Children and Disclosure of Diagnosis?

When a child has HIV, one of the more complex issues is how to disclose this information. The National Pediatric and Family HIV Resource Center summarizes the recommendations on disclosure of diagnosis to children and adolescents living with HIV infection from the American Academy of Pediatrics.

Want to Switch or Stop Therapy?

Is switching or stopping therapy right for you? Read this informative discussion, from Project Inform.

Want to Switch to NNRTIs?

Recently, there has been a lot of talk about switching from a protease inhibitor-based regimen to a non-nucleoside (NNRTI)-based regimen. Why is there so much interest in doing this? Should I consider switching to an NNRTI-based regimen? Project Inform looks at these questions.

Pre-employment Drug Screening

Well, do you think you feel good enough to go back to work? That's great! Your health is good, you have managed the HIV drug regimen and side effects and you are raring to go! Here is something that you probably have not thought about -- pre-employment drug screening. As a pharmacist, I get a lot of questions from HIV-positive people regarding drug tests and how to prepare for them. Click here for the latest information.

Quality of Life Survey

Help Community Research Initiative on AIDS study PWAs' quality of life, take their quality of life survey.

Rural AIDS

AIDS is often seen as an urban disease, one that affects those living in large cities and major metropolitan areas. While it is true that large percentages of people diagnosed with AIDS live in and around large cities, no one can deny that HIV/AIDS is impacting rural communities throughout the United States. Julie Harris, director of education at the AIDS Council of Northeastern New York, discusses some of the challenges of HIV in rural America, in Body Positive.

News Roundup

HIV/AIDS news briefs, from Body Positive.

Lipodystrophy and Women

We don't know what causes it, and we don't really know how to treat it. We do know that it's a syndrome characterized by the redistribution of body fat. The syndrome can also include increased fat in the blood, resulting in abnormally high cholesterol and triglyceride values. The combination of these changes leads to an increased risk of heart disease. Lipodystrophy is increasingly common in people with HIV, and researchers are looking for answers.

Douching Dangers

"Women with HIV are already at greater risk for gynecological problems; douching can complicate the vaginal infections common to women living with HIV/AIDS, possibly leading to serious health problems or an increase in viral load." Laura Jones writes about the dangers of douching, in Positively Aware.

Women on Protease Inhibitors

"Practically speaking, women on protease inhibitors should be counseled on how to alter the dose of their oral contraceptives or hormone replacement therapy to maintain effectiveness and/or use alternative methods of birth control." This tidbit, as well as other crucial notes on how HIV drugs are processed in women can be found in Project Inform's April newsletter.

Medicare and Prescription Drug Coverage

AIDS Action criticized the U.S. Senate for defeating the Baucus-Graham Amendment, a measure calling for increased funds for prescription drug coverage under Medicare. "One in five people living with HIV/AIDS in the United States depends on Medicare for their health care," said Claudia French, executive Director of AIDS Action. "This legislation would have provided the resources necessary for a Medicare prescription drug benefit that would make a real difference for people with living with HIV/AIDS." Click here to read more.

Political Successes, Missed Opportunities and Challenges for 2001

Election year politics kept Congress from completing a lot of work, but there was still quite a bit of activity on HIV/AIDS issues in 2000. Read a brief summary of this year's successes, missed opportunities, and some challenges we face in 2001, in Project Inform's Wise Words.

Valganciclovir and CMV

The Antiviral Drugs Advisory Committee to the Food and Drug Administration recommended that valganciclovir be approved for treating active CMV retinitis and maintenance therapy (to prevent relapse of CMV). Valganciclovir is an improved oral formulation of ganciclovir. Clinical studies show that valganciclovir is as effective as the intravenous (injection into the vein) form of the drug, which is commonly used to treat CMV disease.

STDs and HIV

"HIV and other STDs have a strong interplay. Among men reporting sex with other men who were diagnosed with gonorrhea or syphilis at one of the NYC Department of Health STD Clinics in 1999, thirty-two percent were also HIV-positive." A report from a forum by Community Research Initiative on AIDS.

Chicago Retrovirus Conference Coverage

Coverage is still arriving from the Chicago Retrovirus conference, this time from Seattle Treatment Education Project.

Iron Overload?

As a result of their findings, researchers suggest that iron overload may be a problem that is not usually recognized in HIV-positive drug users taking HAART.

Web Highlights
A Selection of Top HIV/AIDS Stories from Across the Internet

San Francisco Clubs Offer Free Drinks for Sex Disease Test
From the San Francisco Chronicle (April 9, 2001)

Gay Republican to Head White House AIDS Office
Bush names president of Wisconsin Log Cabin group as his first openly Gay appointee
From the Washington Blade (April 9, 2001)

Death Stalks a Continent: AIDS in Africa
From Time Magazine (2001)

AIDS in Africa: One Woman's Struggle
From Time Europe (2001)

Training Manual on STD Case Management/The Syndromic Approach for Primary Health Care Settings
From the World Health Organization, Western Pacific Regional Office (2001)

100% Condom Use Programme in Entertainment (Sex Worker) Establishments
From the World Health Organization, Western Pacific Regional Office (2001)
(Please note this is a PDF and you'll need Adobe Acrobat to read this)

Feasibility of Postexposure Prophylaxis (PEP) Against Human Immunodeficiency Virus Infection After Sexual or Injection Drug Use Exposure: The San Francisco PEP Study
From the AIDS Education Training Center (March 29, 2001)

Overview of Antiretroviral Drugs
New Knowledge Base chapter
From HIVinSite (March 16, 2001)

Previous Update | Next Update
Back to The Body's HIV/AIDS News Updates main page